Stock Earnings

Question 1

Beam Therapeutics Inc'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Beam Therapeutics Inc'in toplam varlıkları $1,103 olup, net loss $-376'dir.

Question 2

BEAM'ün temel finansal oranları nelerdir?

Accepted Answer

Beam Therapeutics Inc'in cari oranı 2.98, net kâr marjı -596.82, hisse başına satış $0.76'dir.

Question 3

Beam Therapeutics Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Beam Therapeutics Inc largest revenue segment is Genetic Medicines, at a revenue of 63,518,000 in the most earnings release.For geography, United States is the primary market for Beam Therapeutics Inc, at a revenue of 63,518,000.

Question 4

Beam Therapeutics Inc kârlı mı?

Accepted Answer

no, son mali tablolara göre Beam Therapeutics Inc'in net loss $-376'dir.

Question 5

Beam Therapeutics Inc'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Beam Therapeutics Inc'in yükümlülüğü 370'dir.

Question 6

Beam Therapeutics Inc'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Beam Therapeutics Inc'in toplam tedavüldeki hisse sayısı 83.63'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	60	63	377	60	51	0
Revenue Growth (YoY)	-83%	-83%	528%	18%	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	109	111	116	87	57	29
Research & Development	396	367	437	311	387	103
Operating Expenses	506	479	554	399	444	132
Other Non Operating Income (Expenses)	0	1	9	18	22	--
Pretax Income	-398	-376	-131	-260	-370	-194
Income Tax Expense	0	0	1	3	--	--
Net Income	-398	-376	-132	-289	-370	-195
Net Income Growth	178%	185%	-54%	-22%	90%	113.99%
Shares Outstanding (Diluted)	101.99	82.31	77.15	70.02	64.23	46.73
Shares Change (YoY)	24%	7%	10%	9%	37%	3%
EPS (Diluted)	-3.9	-4.57	-1.71	-4.13	-5.77	-4.19
EPS Growth	125%	166%	-57.99%	-28%	38%	108%
Free Cash Flow	-355	-356	-182	-26	-113	-112
Free Cash Flow Per Share	-3.48	-4.32	-2.35	-0.37	-1.75	-2.39
Gross Margin	--	--	--	--	--	--
Operating Margin	-741.66%	-658.73%	-46.68%	-563.33%	-768.62%	0%
Profit Margin	-663.33%	-596.82%	-35.01%	-481.66%	-725.49%	0%
Free Cash Flow Margin	-591.66%	-565.07%	-48.27%	-43.33%	-221.56%	0%
EBITDA	-424	-394	-156	-324	-385	-128
EBITDA Margin	-706.66%	-625.39%	-41.37%	-540%	-754.9%	0%
D&A For EBITDA	21	21	20	14	7	4
EBIT	-445	-415	-176	-338	-392	-132
EBIT Margin	-741.66%	-658.73%	-46.68%	-563.33%	-768.62%	0%
Effective Tax Rate	0%	0%	-0.76%	-1.15%	--	--

Beam Therapeutics Inc (BEAM) Price

BEAM Stock Price Chart

BEAM Income

Follow-Up Questions